hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
about
hERG 1b is critical for human cardiac repolarizationhERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.Dominant negative consequences of a hERG 1b-specific mutation associated with intrauterine fetal death.Modulation of Kv 11.1 (hERG) channels by 5-(((1H-indazol-5-yl)oxy)methyl)-N-(4-(trifluoromethoxy)phenyl)pyrimidin-2-amine (ITP-2), a novel small molecule activator.
P2860
hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@en
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@nl
type
label
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@en
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@nl
prefLabel
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@en
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@nl
P2093
P2860
P1476
hERG1a/1b heteromeric currents ...... n variant 1 short QT syndrome.
@en
P2093
C E Dempsey
H J Witchel
J C Hancox
J M Cordeiro
M J McPate
P2860
P304
P356
10.1016/J.BBRC.2009.05.134
P577
2009-06-06T00:00:00Z